Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I

被引:58
|
作者
Hedstrand, H [1 ]
Ekwall, O
Haavik, J
Landgren, E
Betterle, C
Perheentupa, J
Gustafsson, J
Husebye, E
Rorsman, F
Kämpe, O
机构
[1] Univ Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden
[2] Univ Hosp, Dept Womens & Childrens Hlth, SE-75185 Uppsala, Sweden
[3] Univ Bergen, Dept Biochem & Mol Biol, Bergen, Norway
[4] Univ Padua, Inst Semeiot Med Clin Immunol & Allergy, Padua, Italy
[5] Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland
[6] Haukeland Univ Hosp, Div Endocrinol, Inst Med, N-5021 Bergen, Norway
关键词
alopecia areata; catecholamine biosynthesis; autoantibodies; tyrosine; 3-monooxygenase;
D O I
10.1006/bbrc.1999.1945
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Patients with the autosomal recessively inherited autoimmune polyendocrine syndrome type I (APS I) have autoantibodies directed against several endocrine and nonendocrine organs. In this study a new autoantigen related to this syndrome, tyrosine hydroxylase, was identified in sera from patients with alopecia areata through immunoscreening of a scalp cDNA library. Immunoreactivity against in vitro expressed tyrosine hydroxylase was found in 41 (44%) of the 94 APS I patients studied and this reactivity correlated with the presence of alopecia areata (P = 0.02). These findings further stress the importance of enzymes involved in neurotransmitter biosynthesis as important immune targets in APS I. (C) 2000 Academic Press.
引用
收藏
页码:456 / 461
页数:6
相关论文
共 50 条
  • [1] Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I)
    Oftedal, Bergithe E. V.
    Wolff, Anette S. Boe
    Kampe, Olle
    Husebye, Eystein
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 71 (06) : 493 - 494
  • [2] Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen
    Alimohammadi, Mohammad
    Dubois, Noemie
    Skoldberg, Filip
    Hallgren, Asa
    Tardivel, Isabelle
    Hedstrand, Hakan
    Haavik, Jan
    Husebye, Eystein S.
    Gustafsson, Jan
    Rorsman, Fredrik
    Meloni, Antonella
    Janson, Christer
    Vialettes, Bernard
    Kajosaari, Merja
    Egner, William
    Sargur, Ravishankar
    Ponten, Fredrik
    Amoura, Zahir
    Grimfeld, Alain
    De Luca, Filippo
    Betterle, Corrado
    Perheentupa, Jaakko
    Kampe, Olle
    Carel, Jean-Claude
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (11) : 4396 - 4401
  • [3] Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1
    Smith-Anttila, Casey J. A.
    Bensing, Sophie
    Alimohammadi, Mohammad
    Dalin, Frida
    Oscarson, Mikael
    Zhang, Ming-Dong
    Perheentupa, Jaakko
    Husebye, Eystein S.
    Gustafsson, Jan
    Bjorklund, Peyman
    Fransson, Anette
    Nordmark, Gunnel
    Ronnblom, Lars
    Meloni, Antonella
    Scott, Rodney J.
    Hokfelt, Tomas
    Crock, Patricia A.
    Kampe, Olle
    AUTOIMMUNITY, 2017, 50 (04) : 223 - 231
  • [4] Autoimmune Retinopathy in a Patient with Autoimmune Polyendocrine Syndrome Type I
    Breunig, Adam
    Lee, Michael S.
    Miller, Bradley S.
    Binstadt, Bryce A.
    Anderson, Mark S.
    Montezuma, Sandra
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (02) : 153 - 157
  • [5] Autoimmune polyendocrine syndrome type 1 and NALP5, parathyroid autoantigen
    Alimohammadi, Mohammad
    Bjorklund, Peyman
    Hallgren, Asa
    Pontynen, Nora
    Szinnai, Gabor
    Shikama, Noriko
    Keller, Marcel P.
    Ekwall, Olov
    Kinkel, Sarah A.
    Husebye, Eystein S.
    Gustafsson, Jan
    Rorsman, Fredrik
    Peltonen, Leena
    Betterle, Corrado
    Perheentupa, Jaakko
    Akerstrom, Goran
    Westin, Gunnar
    Scott, Hamish S.
    Hollaender, Georg A.
    Kampe, Olle
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (10): : 1018 - 1028
  • [6] Autoimmune polyendocrine syndrome type I and brain calcinosis
    Abraham, Alon
    Ziv, Ilan
    Steinmetz, Adam
    Groshar, David
    Djaldetti, Ruth
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (02) : 101 - 104
  • [7] 21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I
    Berglund, A.
    Cleemann, L.
    Oftedal, B. E.
    Holm, K.
    Husebye, E. S.
    Gravholt, C. H.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 195 (03): : 364 - 368
  • [8] Tryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type 1
    Ekwall, O
    Sjöberg, K
    Mirakian, R
    Rorsman, F
    Kämpe, O
    LANCET, 1999, 354 (9178): : 568 - 568
  • [9] Autoimmune polyendocrine syndrome type 1 (APS I) in Norway
    Myhre, AG
    Halonen, M
    Eskelin, P
    Ekwall, O
    Hedstrand, H
    Rorsman, F
    Kämpe, O
    Husebye, ES
    CLINICAL ENDOCRINOLOGY, 2001, 54 (02) : 211 - 217
  • [10] Autoimmune polyendocrine syndrome type 1
    Proust-Lemoine, E.
    Saugier-Veber, P.
    Lefebvre, H.
    Lefranc, D.
    Prin, L.
    Weill, J.
    Carel, J. -C.
    Wemeau, J. -L.
    ARCHIVES DE PEDIATRIE, 2010, 17 (06): : 597 - 598